Welcome Guest
Home > Clinical Lymphoma & Myeloma > Volume 4 |  Issue 1

Table of Contents

Volume 4 |  Issue 1

Publication Date: June 2003
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
9		 Minimal Residual Disease in Lymphoma Revisited
Anton Hagenbeek
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
10-15		 From: 44th Annual Meeting of the American Society of Hematology, Philadelphia, Pennsylvania
Heather DeGrendele, Angelia D. Gibson, Mary Hightower, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Research in Brief
Page Number of this Article in the Print Version
19-21		 Factors Predicting the Response to Rituximab in Indolent Lymphoma
David Lee, Vinay K. Jain, Peter McLaughlin
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
22-29		 Primary Ocular Lymphoma: Clinical Features, Diagnosis, and Treatment
Adília Hormigo, Lisa M. DeAngelis
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
30-31		 Primary Intraocular Lymphoma: Clinical Features, Diagnosis, and Treatment
Chi-Chao Chan
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
32-35		 Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival
Maurizio Zangari, Bart Barlogie, Raymond Thertulien, Joth Jacobson, Paul Eddleman, Louis Fink, Athanasios Fassas, Frits Van Rhee, Giampaolo Talamo, Choon-Kee Lee, Guido Tricot
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
36-42		 First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin’s Lymphoma: Phase II Trial
John D. Hainsworth, Sharlene Litchy, M. Ray Lamb, Gladys I. Rodriguez, Carroll Scroggin, Jr., F. Anthony Greco
  • Abstract
  • No Access
  • Add to Cart
Imaging in Lymphoma
Page Number of this Article in the Print Version
43-49		 Frequent Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography on the Staging and Management of Patients with Indolent Non-Hodgkin’s Lymphoma
Robert H. Blum, John F. Seymour, Andrew Wirth, Michael MacManus, Rodney J. Hicks
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
50-51		 Positron Emission Tomography in the Management of Patients with Indolent Non-Hodgkin’s Lymphoma
Ralph Naumann, Bettina Beuthien-Baumann
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
52-55		 Prognostic Significance of the Immunophenotype Versus the International Prognostic Index in Aggressive Non-Hodgkin’s Lymphoma
Tanin Intragumtornchai, Ponlapat Rotnakkarin, Pranee Sutcharitchan, Pongsak Wannagrairoj
  • Abstract
  • No Access
  • Add to Cart
Case Report
Page Number of this Article in the Print Version
56-59		 Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin’s Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody
Donald E. Tsai, Ivan Maillard, Stephen J. Schuster, Sunita D. Nasta, David L. Porter, Thomas R. Klumpp, David M. Goldenberg, Selina M. Luger, Abass Alavi, Robert M. Sharkey, Kenneth B. Hartzell, Edward A. Stadtmauer
  • Abstract
  • No Access
  • Add to Cart